Seven Bridges Stock

Biomedical Data Science Company

Sign up today and learn more about Seven Bridges Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.



Notable Investors

Kryssen Capital


Charlestown MA, US

Total Funding


About Seven Bridges Stock

Seven Bridges is the industry-leading infrastructure and data analytics company accelerating precision medicine by enabling the understanding of biomedical data. Our platform, services, and support expertise are driving discovery and drug development at the world’s leading academic, biotechnology, government, hospitals, and pharmaceutical entities. Through our collaborations with the largest genomics projects, we connect the world’s biomedical information to enable the most efficient analysis at scale. Named one of the world's smartest companies by MIT Technology Review, and a three-time Bio-IT World Best of Show winner, Seven Bridges has offices in Belgrade, Boston, Istanbul, and San Francisco.


First Star Ventures

Swiftly, Seven Bridges

Kryssen Capital

Seven Bridges

Funding History

September 2014$3.0M
February 2016$45.0M
April 2018$50.0M
April 2021$15.0M


Chief Executive Officer

William Moss

Chief Financial Officer

Robert Shay

Chief Technology Officer

David Ramos


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 300K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: